Prenatis™ was investigated in a large-scale, gold standard clinical trial with rigorous measurements of several parameters in 180 healthy pregnant women during their third trimester. Follow-ups were conducted on mothers and their babies up to one year old. The study reveals positive outcomes in maintaining a healthy pregnancy and contributing to the establishment of a healthy infant microbiome.
Prenatis™ can be combined with other probiotic strains and enriched with valuable ingredients. This probiotic formula is available in multiple convenient formats, including powder in sachets or sticks, orodispersible powder, and capsules in blisters or bottles. This flexibility ensures ease of use for expectant mothers.
Prenatis™ represents a significant leap in perinatal health, supporting both maternal well-being and the foundation of a healthy infant microbiome during the first months of life. Be amongst the first to know more about this innovative product.
